174 related articles for article (PubMed ID: 37753803)
21. Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia.
Gugliotta G; Sudo M; Cao Q; Lin DC; Sun H; Takao S; Le Moigne R; Rolfe M; Gery S; Müschen M; Cavo M; Koeffler HP
Neoplasia; 2017 Oct; 19(10):750-761. PubMed ID: 28843399
[TBL] [Abstract][Full Text] [Related]
22. Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children with Acute Lymphoblastic Leukemia.
Kaur M; de Smith AJ; Selvin S; Zhang L; Cunningham M; Kang MW; Hansen HM; Cooper RM; McKean-Cowdin R; Wiemels JL; Metayer C
Arch Med Res; 2016 Nov; 47(8):677-683. PubMed ID: 28476195
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
Messina M; Chiaretti S; Fedullo AL; Piciocchi A; Puzzolo MC; Lauretti A; Gianfelici V; Apicella V; Fazi P; Te Kronnie G; Testi AM; Vitale A; Guarini A; Foà R
Br J Haematol; 2017 Aug; 178(4):583-587. PubMed ID: 28439887
[TBL] [Abstract][Full Text] [Related]
24. Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.
Posch C; Moslehi H; Feeney L; Green GA; Ebaee A; Feichtenschlager V; Chong K; Peng L; Dimon MT; Phillips T; Daud AI; McCalmont TH; LeBoit PE; Ortiz-Urda S
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4015-20. PubMed ID: 23431193
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide mRNA profiling identifies X-box-binding protein 1 (XBP1) as an IRE1 and PUMA repressor.
Gebert M; Sobolewska A; Bartoszewska S; Cabaj A; Crossman DK; Króliczewski J; Madanecki P; Dąbrowski M; Collawn JF; Bartoszewski R
Cell Mol Life Sci; 2021 Nov; 78(21-22):7061-7080. PubMed ID: 34636989
[TBL] [Abstract][Full Text] [Related]
26. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.
Blazanin N; Son J; Craig-Lucas AB; John CL; Breech KJ; Podolsky MA; Glick AB
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9900-9905. PubMed ID: 28847931
[TBL] [Abstract][Full Text] [Related]
27. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
28. Expression of UPR effector proteins ATF6 and XBP1 reduce colorectal cancer cell proliferation and stemness by activating PERK signaling.
Spaan CN; Smit WL; van Lidth de Jeude JF; Meijer BJ; Muncan V; van den Brink GR; Heijmans J
Cell Death Dis; 2019 Jun; 10(7):490. PubMed ID: 31227689
[TBL] [Abstract][Full Text] [Related]
29. Mutations that collaborate with IL-7Ra signaling pathways to drive ALL.
Rodrigues GOL; Cramer SD; Winer HY; Hixon JA; Li W; Yunes JA; Durum SK
Adv Biol Regul; 2021 May; 80():100788. PubMed ID: 33578108
[TBL] [Abstract][Full Text] [Related]
30. X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver.
Argemí J; Kress TR; Chang HCY; Ferrero R; Bértolo C; Moreno H; González-Aparicio M; Uriarte I; Guembe L; Segura V; Hernández-Alcoceba R; Ávila MA; Amati B; Prieto J; Aragón T
Gastroenterology; 2017 Apr; 152(5):1203-1216.e15. PubMed ID: 28082079
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.
Zhao N; Cao J; Xu L; Tang Q; Dobrolecki LE; Lv X; Talukdar M; Lu Y; Wang X; Hu DZ; Shi Q; Xiang Y; Wang Y; Liu X; Bu W; Jiang Y; Li M; Gong Y; Sun Z; Ying H; Yuan B; Lin X; Feng XH; Hartig SM; Li F; Shen H; Chen Y; Han L; Zeng Q; Patterson JB; Kaipparettu BA; Putluri N; Sicheri F; Rosen JM; Lewis MT; Chen X
J Clin Invest; 2018 Apr; 128(4):1283-1299. PubMed ID: 29480818
[TBL] [Abstract][Full Text] [Related]
34. Analysis of RAS oncogene mutations in human lymphoid malignancies.
Neri A; Knowles DM; Greco A; McCormick F; Dalla-Favera R
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9268-72. PubMed ID: 3057505
[TBL] [Abstract][Full Text] [Related]
35. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
Uckun FM; Qazi S; Ozer Z; Garner AL; Pitt J; Ma H; Janda KD
Br J Haematol; 2011 Jun; 153(6):741-52. PubMed ID: 21517817
[TBL] [Abstract][Full Text] [Related]
36. Anti-leukemic effects of simvastatin on NRAS
Jang J; Lee J; Jang JH; Jung CW; Park S
Mol Biol Rep; 2019 Dec; 46(6):5859-5866. PubMed ID: 31452046
[TBL] [Abstract][Full Text] [Related]
37.
Bartoszewska S; Cabaj A; Dąbrowski M; Collawn JF; Bartoszewski R
FASEB J; 2019 Oct; 33(10):11541-11554. PubMed ID: 31314593
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.
Li Q; Bohin N; Wen T; Ng V; Magee J; Chen SC; Shannon K; Morrison SJ
Nature; 2013 Dec; 504(7478):143-147. PubMed ID: 24284627
[TBL] [Abstract][Full Text] [Related]
39. Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.
Vieri M; Preisinger C; Schemionek M; Salimi A; Patterson JB; Samali A; Brümmendorf TH; Appelmann I; Kharabi Masouleh B
Carcinogenesis; 2021 Feb; 42(2):272-284. PubMed ID: 32915195
[TBL] [Abstract][Full Text] [Related]
40. XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease.
Piróg KA; Dennis EP; Hartley CL; Jackson RM; Soul J; Schwartz JM; Bateman JF; Boot-Handford RP; Briggs MD
PLoS Genet; 2019 Jul; 15(7):e1008215. PubMed ID: 31260448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
